NCT04972175View on ClinicalTrials.gov

Safety and Efficacy of BC LisPram

PHASE1UnknownINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Type1 Diabetes Mellitus
Interventions
DRUG

50-Hour Intervention - Rapid Insulin lispro

Subcutaneous-delivery of insulin lispro using pump therapy.

DRUG

50-Hour Intervention - BC LisPram

Subcutaneous-delivery of BC LisPram using pump therapy.

Trial Locations (1)

H4A3T2

RECRUITING

Hygea Medical Clinic, Montreal

Sponsors

Collaborators (1)

Adocia
All Listed Sponsors
collaborator

Adocia

INDUSTRY

lead

Michael Tsoukas

NETWORK